BioCentury
ARTICLE | Company News

PrimeraDx, National Cancer Institute pharmacogenetics news

October 1, 2012 7:00 AM UTC

PrimeraDx received a grant from the institute's Innovative Molecular Analysis Technologies program to develop an assay to rapidly detect diffuse large B cell lymphoma subgroups. PrimeraDx will use its...